Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Exact Sciences Corp.’s stock clocked out at $58.97, up 0.37% from its previous closing price of $58.75. In other words, the price has increased by $0.37 from its previous closing price. On the day, 1.15 million shares were traded. EXAS stock price reached its highest trading level at $59.48 during the session, while it also had its lowest trading level at $58.0525.
Ratios:
To gain a deeper understanding of EXAS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.17. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on June 27, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $70.
The Benchmark Company Upgraded its Hold to Buy on January 02, 2024, while the target price for the stock was maintained at $91.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when COWARD D SCOTT sold 67 shares for $60.15 per share. The transaction valued at 4,030 led to the insider holds 44,644 shares of the business.
Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Herriott James, who serves as the SVP, General Counsel & Sec of the company, sold 30 shares for $60.15 each. As a result, the insider received 1,804 and left with 9,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 10895887360 and an Enterprise Value of 12733028352. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.17 while its Price-to-Book (P/B) ratio in mrq is 3.41. Its current Enterprise Value per Revenue stands at 4.875 whereas that against EBITDA is -184.802.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $85.71, while it has fallen to a 52-week low of $40.62. The 50-Day Moving Average of the stock is 23.40%, while the 200-Day Moving Average is calculated to be -0.09%.
Shares Statistics:
It appears that EXAS traded 3.06M shares on average per day over the past three months and 1859770 shares per day over the past ten days. A total of 184.77M shares are outstanding, with a floating share count of 181.87M. Insiders hold about 1.57% of the company’s shares, while institutions hold 97.37% stake in the company. Shares short for EXAS as of 1722384000 were 13592719 with a Short Ratio of 4.45, compared to 1719532800 on 14212881. Therefore, it implies a Short% of Shares Outstanding of 13592719 and a Short% of Float of 7.430000000000001.
